 | • レポートコード：MRC2102QY10016 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の腫瘍学注射薬市場について種類別（臓器、中枢神経系、循環器系/筋骨格系、その他）、用途別（リンパ腫、骨髄腫、前立腺がん、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・腫瘍学注射薬市場の概要 ・世界の主要地域別腫瘍学注射薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の腫瘍学注射薬市場規模2015-2026：種類別（臓器、中枢神経系、循環器系/筋骨格系、その他） ・世界の腫瘍学注射薬市場規模2015-2026：用途別（リンパ腫、骨髄腫、前立腺がん、その他） ・腫瘍学注射薬の米国市場規模2015-2020 ・腫瘍学注射薬のヨーロッパ市場規模2015-2020 ・腫瘍学注射薬の中国市場規模2015-2020 ・腫瘍学注射薬の日本市場規模2015-2020 ・腫瘍学注射薬の東南アジア市場規模2015-2020 ・腫瘍学注射薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・腫瘍学注射薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・腫瘍学注射薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Oncology Injection Drug Market
The global Oncology Injection Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Oncology Injection Drug Scope and Market Size
The global Oncology Injection Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Injection Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Oncology Injection Drug market is segmented into
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other
Segment by Application, the Oncology Injection Drug market is segmented into
Lymphoma
Myeloma
Prostate Cancer
Other
The Oncology Injection Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Oncology Injection Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oncology Injection Drug Market Share Analysis
Oncology Injection Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Injection Drug business, the date to enter into the Oncology Injection Drug market, Oncology Injection Drug product introduction, recent developments, etc.
The major vendors covered:
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
1 Oncology Injection Drug Market Overview
1.1 Oncology Injection Drug Product Scope
1.2 Oncology Injection Drug Segment by Type
1.2.1 Global Oncology Injection Drug Sales by Type (2020-2026)
1.2.2 Organs
1.2.3 Central Nervous System
1.2.4 Circulatory/Musculoskeletal System
1.2.5 Other
1.3 Oncology Injection Drug Segment by Application
1.3.1 Global Oncology Injection Drug Sales Comparison by Application (2020-2026)
1.3.2 Lymphoma
1.3.3 Myeloma
1.3.4 Prostate Cancer
1.3.5 Other
1.4 Oncology Injection Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oncology Injection Drug Sales Growth Rate (2015-2026)
1.4.2 Global Oncology Injection Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Oncology Injection Drug Price Trends (2015-2026)
2 Oncology Injection Drug Estimate and Forecast by Region
2.1 Global Oncology Injection Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oncology Injection Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oncology Injection Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Oncology Injection Drug Revenue Market Share by Region (2015-2020)
2.3 Global Oncology Injection Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oncology Injection Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oncology Injection Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oncology Injection Drug Estimates and Projections (2015-2026)
2.4.2 Europe Oncology Injection Drug Estimates and Projections (2015-2026)
2.4.3 China Oncology Injection Drug Estimates and Projections (2015-2026)
2.4.4 Japan Oncology Injection Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oncology Injection Drug Estimates and Projections (2015-2026)
2.4.6 India Oncology Injection Drug Estimates and Projections (2015-2026)
3 Global Oncology Injection Drug Competition Landscape by Players
3.1 Global Top Oncology Injection Drug Players by Sales (2015-2020)
3.2 Global Top Oncology Injection Drug Players by Revenue (2015-2020)
3.3 Global Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Injection Drug as of 2019)
3.4 Global Oncology Injection Drug Average Price by Company (2015-2020)
3.5 Manufacturers Oncology Injection Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oncology Injection Drug Players (Opinion Leaders)
4 Global Oncology Injection Drug Market Size by Type
4.1 Global Oncology Injection Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Oncology Injection Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Oncology Injection Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Oncology Injection Drug Price by Type (2015-2020)
4.2 Global Oncology Injection Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oncology Injection Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Oncology Injection Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Oncology Injection Drug Price Forecast by Type (2021-2026)
5 Global Oncology Injection Drug Market Size by Application
5.1 Global Oncology Injection Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Oncology Injection Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Oncology Injection Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Oncology Injection Drug Price by Application (2015-2020)
5.2 Global Oncology Injection Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oncology Injection Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Oncology Injection Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Oncology Injection Drug Price Forecast by Application (2021-2026)
6 United States Oncology Injection Drug Market Facts & Figures
6.1 United States Oncology Injection Drug Sales Market Share by Company (2015-2020)
6.2 United States Oncology Injection Drug Sales Market Share by Type (2015-2020)
6.3 United States Oncology Injection Drug Sales Market Share by Application (2015-2020)
7 Europe Oncology Injection Drug Market Facts & Figures
7.1 Europe Oncology Injection Drug Sales Market Share by Company (2015-2020)
7.2 Europe Oncology Injection Drug Sales Market Share by Type (2015-2020)
7.3 Europe Oncology Injection Drug Sales Market Share by Application (2015-2020)
8 China Oncology Injection Drug Market Facts & Figures
8.1 China Oncology Injection Drug Sales Market Share by Company (2015-2020)
8.2 China Oncology Injection Drug Sales Market Share by Type (2015-2020)
8.3 China Oncology Injection Drug Sales Market Share by Application (2015-2020)
9 Japan Oncology Injection Drug Market Facts & Figures
9.1 Japan Oncology Injection Drug Sales Market Share by Company (3015-3030)
9.2 Japan Oncology Injection Drug Sales Market Share by Type (2015-2020)
9.3 Japan Oncology Injection Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Oncology Injection Drug Market Facts & Figures
10.1 Southeast Asia Oncology Injection Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Oncology Injection Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Oncology Injection Drug Sales Market Share by Application (2015-2020)
11 India Oncology Injection Drug Market Facts & Figures
11.1 India Oncology Injection Drug Sales Market Share by Company (2015-2020)
11.2 India Oncology Injection Drug Sales Market Share by Type (2015-2020)
11.3 India Oncology Injection Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Oncology Injection Drug Business
12.1 Taj Oncology
12.1.1 Taj Oncology Corporation Information
12.1.2 Taj Oncology Business Overview
12.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Taj Oncology Oncology Injection Drug Products Offered
12.1.5 Taj Oncology Recent Development
12.2 S.G. Biopharm
12.2.1 S.G. Biopharm Corporation Information
12.2.2 S.G. Biopharm Business Overview
12.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 S.G. Biopharm Oncology Injection Drug Products Offered
12.2.5 S.G. Biopharm Recent Development
12.3 AdvaCare
12.3.1 AdvaCare Corporation Information
12.3.2 AdvaCare Business Overview
12.3.3 AdvaCare Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AdvaCare Oncology Injection Drug Products Offered
12.3.5 AdvaCare Recent Development
12.4 Merrimack
12.4.1 Merrimack Corporation Information
12.4.2 Merrimack Business Overview
12.4.3 Merrimack Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merrimack Oncology Injection Drug Products Offered
12.4.5 Merrimack Recent Development
12.5 Celgene
12.5.1 Celgene Corporation Information
12.5.2 Celgene Business Overview
12.5.3 Celgene Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Celgene Oncology Injection Drug Products Offered
12.5.5 Celgene Recent Development
12.6 Allos Therapeutics
12.6.1 Allos Therapeutics Corporation Information
12.6.2 Allos Therapeutics Business Overview
12.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Allos Therapeutics Oncology Injection Drug Products Offered
12.6.5 Allos Therapeutics Recent Development
12.7 Ferring Pharmaceuticals
12.7.1 Ferring Pharmaceuticals Corporation Information
12.7.2 Ferring Pharmaceuticals Business Overview
12.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Ferring Pharmaceuticals Oncology Injection Drug Products Offered
12.7.5 Ferring Pharmaceuticals Recent Development
12.8 Genzyme
12.8.1 Genzyme Corporation Information
12.8.2 Genzyme Business Overview
12.8.3 Genzyme Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Genzyme Oncology Injection Drug Products Offered
12.8.5 Genzyme Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Corporation Information
12.9.2 Eli Lilly Business Overview
12.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Eli Lilly Oncology Injection Drug Products Offered
12.9.5 Eli Lilly Recent Development
12.10 Praecis Pharmaceuticals
12.10.1 Praecis Pharmaceuticals Corporation Information
12.10.2 Praecis Pharmaceuticals Business Overview
12.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Praecis Pharmaceuticals Oncology Injection Drug Products Offered
12.10.5 Praecis Pharmaceuticals Recent Development
12.11 Millennium Pharmaceuticals
12.11.1 Millennium Pharmaceuticals Corporation Information
12.11.2 Millennium Pharmaceuticals Business Overview
12.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Millennium Pharmaceuticals Oncology Injection Drug Products Offered
12.11.5 Millennium Pharmaceuticals Recent Development
12.12 Debiopharm
12.12.1 Debiopharm Corporation Information
12.12.2 Debiopharm Business Overview
12.12.3 Debiopharm Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Debiopharm Oncology Injection Drug Products Offered
12.12.5 Debiopharm Recent Development
12.13 Alza
12.13.1 Alza Corporation Information
12.13.2 Alza Business Overview
12.13.3 Alza Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Alza Oncology Injection Drug Products Offered
12.13.5 Alza Recent Development
12.14 CordenPharma
12.14.1 CordenPharma Corporation Information
12.14.2 CordenPharma Business Overview
12.14.3 CordenPharma Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 CordenPharma Oncology Injection Drug Products Offered
12.14.5 CordenPharma Recent Development
12.15 Pharmascience
12.15.1 Pharmascience Corporation Information
12.15.2 Pharmascience Business Overview
12.15.3 Pharmascience Oncology Injection Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Pharmascience Oncology Injection Drug Products Offered
12.15.5 Pharmascience Recent Development
13 Oncology Injection Drug Manufacturing Cost Analysis
13.1 Oncology Injection Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oncology Injection Drug
13.4 Oncology Injection Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oncology Injection Drug Distributors List
14.3 Oncology Injection Drug Customers
15 Market Dynamics
15.1 Oncology Injection Drug Market Trends
15.2 Oncology Injection Drug Opportunities and Drivers
15.3 Oncology Injection Drug Market Challenges
15.4 Oncology Injection Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Oncology Injection Drug Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Oncology Injection Drug Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Oncology Injection Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Oncology Injection Drug Sales (MT) by Region (2015-2020)
Table 5. Global Oncology Injection Drug Sales Market Share by Region (2015-2020)
Table 6. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Oncology Injection Drug Revenue Share by Region (2015-2020)
Table 8. Global Oncology Injection Drug Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Oncology Injection Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Oncology Injection Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Oncology Injection Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Oncology Injection Drug (MT) of Key Companies (2015-2020)
Table 13. Global Oncology Injection Drug Sales Share by Company (2015-2020)
Table 14. Global Oncology Injection Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Oncology Injection Drug Revenue Share by Company (2015-2020)
Table 16. Global Oncology Injection Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Injection Drug as of 2019)
Table 17. Global Oncology Injection Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Oncology Injection Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Oncology Injection Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Oncology Injection Drug Players
Table 22. Global Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 23. Global Oncology Injection Drug Sales Share by Type (2015-2020)
Table 24. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Oncology Injection Drug Price (MT) by Type (2015-2020)
Table 26. Global Oncology Injection Drug Sales Share by Type (2021-2026)
Table 27. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Oncology Injection Drug Revenue Share by Type (2021-2026)
Table 29. Global Oncology Injection Drug Price (MT) by Type (2021-2026)
Table 30. Global Oncology Injection Drug Sales (MT) by Application (2015-2020)
Table 31. Global Oncology Injection Drug Sales Share by Application (2015-2020)
Table 32. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Oncology Injection Drug Price (MT) by Application (2015-2020)
Table 34. Global Oncology Injection Drug Sales (MT) by Application (2021-2026)
Table 35. Global Oncology Injection Drug Sales Share by Application (2021-2026)
Table 36. Global Oncology Injection Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Oncology Injection Drug Revenue Share by Application (2021-2026)
Table 38. Global Oncology Injection Drug Price (MT) by Application (2021-2026)
Table 39. United States Oncology Injection Drug Sales (MT) by Company (2015-2020)
Table 40. United States Oncology Injection Drug Sales Market Share by Company (2015-2020)
Table 41. United States Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 42. United States Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 43. United States Oncology Injection Drug Sales (MT) by Application (2015-2020)
Table 44. United States Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Oncology Injection Drug Sales (MT) by Company (2015-2020)
Table 46. Europe Oncology Injection Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 48. Europe Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Oncology Injection Drug Sales (MT) by Application (2015-2020)
Table 50. Europe Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 51. China Oncology Injection Drug Sales (MT) by Company (2015-2020)
Table 52. China Oncology Injection Drug Sales Market Share by Company (2015-2020)
Table 53. China Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 54. China Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 55. China Oncology Injection Drug Sales (MT) by Application (2015-2020)
Table 56. China Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Oncology Injection Drug Sales (MT) by Company (2015-2020)
Table 58. Japan Oncology Injection Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 60. Japan Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Oncology Injection Drug Sales (MT) by Application (2015-2020)
Table 62. Japan Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Oncology Injection Drug Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Oncology Injection Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 69. India Oncology Injection Drug Sales (MT) by Company (2015-2020)
Table 70. India Oncology Injection Drug Sales Market Share by Company (2015-2020)
Table 71. India Oncology Injection Drug Sales (MT) by Type (2015-2020)
Table 72. India Oncology Injection Drug Sales Market Share by Type (2015-2020)
Table 73. India Oncology Injection Drug Sales (MT) by Application (2015-2020)
Table 74. India Oncology Injection Drug Sales Market Share by Application (2015-2020)
Table 75. Taj Oncology Corporation Information
Table 76. Taj Oncology Description and Business Overview
Table 77. Taj Oncology Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Taj Oncology Oncology Injection Drug Product
Table 79. Taj Oncology Recent Development
Table 80. S.G. Biopharm Corporation Information
Table 81. S.G. Biopharm Description and Business Overview
Table 82. S.G. Biopharm Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. S.G. Biopharm Oncology Injection Drug Product
Table 84. S.G. Biopharm Recent Development
Table 85. AdvaCare Corporation Information
Table 86. AdvaCare Description and Business Overview
Table 87. AdvaCare Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. AdvaCare Oncology Injection Drug Product
Table 89. AdvaCare Recent Development
Table 90. Merrimack Corporation Information
Table 91. Merrimack Description and Business Overview
Table 92. Merrimack Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Merrimack Oncology Injection Drug Product
Table 94. Merrimack Recent Development
Table 95. Celgene Corporation Information
Table 96. Celgene Description and Business Overview
Table 97. Celgene Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Celgene Oncology Injection Drug Product
Table 99. Celgene Recent Development
Table 100. Allos Therapeutics Corporation Information
Table 101. Allos Therapeutics Description and Business Overview
Table 102. Allos Therapeutics Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Allos Therapeutics Oncology Injection Drug Product
Table 104. Allos Therapeutics Recent Development
Table 105. Ferring Pharmaceuticals Corporation Information
Table 106. Ferring Pharmaceuticals Description and Business Overview
Table 107. Ferring Pharmaceuticals Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Ferring Pharmaceuticals Oncology Injection Drug Product
Table 109. Ferring Pharmaceuticals Recent Development
Table 110. Genzyme Corporation Information
Table 111. Genzyme Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Genzyme Description and Business Overview
Table 113. Genzyme Oncology Injection Drug Product
Table 114. Genzyme Recent Development
Table 115. Eli Lilly Corporation Information
Table 116. Eli Lilly Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Eli Lilly Description and Business Overview
Table 118. Eli Lilly Oncology Injection Drug Product
Table 119. Eli Lilly Recent Development
Table 120. Praecis Pharmaceuticals Corporation Information
Table 121. Praecis Pharmaceuticals Description and Business Overview
Table 122. Praecis Pharmaceuticals Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Praecis Pharmaceuticals Oncology Injection Drug Product
Table 124. Praecis Pharmaceuticals Recent Development
Table 125. Millennium Pharmaceuticals Corporation Information
Table 126. Millennium Pharmaceuticals Description and Business Overview
Table 127. Millennium Pharmaceuticals Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Millennium Pharmaceuticals Oncology Injection Drug Product
Table 129. Millennium Pharmaceuticals Recent Development
Table 130. Debiopharm Corporation Information
Table 131. Debiopharm Description and Business Overview
Table 132. Debiopharm Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Debiopharm Oncology Injection Drug Product
Table 134. Debiopharm Recent Development
Table 135. Alza Corporation Information
Table 136. Alza Description and Business Overview
Table 137. Alza Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Alza Oncology Injection Drug Product
Table 139. Alza Recent Development
Table 140. CordenPharma Corporation Information
Table 141. CordenPharma Description and Business Overview
Table 142. CordenPharma Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. CordenPharma Oncology Injection Drug Product
Table 144. CordenPharma Recent Development
Table 145. Pharmascience Corporation Information
Table 146. Pharmascience Description and Business Overview
Table 147. Pharmascience Oncology Injection Drug Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Pharmascience Oncology Injection Drug Product
Table 149. Pharmascience Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Oncology Injection Drug Distributors List
Table 153. Oncology Injection Drug Customers List
Table 154. Oncology Injection Drug Market Key Trends
Table 155. Oncology Injection Drug Key Opportunities and Drivers
Table 156. Oncology Injection Drug Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology Injection Drug Product Picture
Figure 2. Global Oncology Injection Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oncology Injection Drug Market Share by Application in 2020 & 2026
Figure 6. Lymphoma Examples
Figure 7. Myeloma Examples
Figure 8. Prostate Cancer Examples
Figure 9. Other Examples
Figure 10. Global Oncology Injection Drug Sales (MT) Growth Rate (2015-2026)
Figure 11. Global Oncology Injection Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Oncology Injection Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Oncology Injection Drug Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Oncology Injection Drug Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Oncology Injection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Oncology Injection Drug Sales (MT) Growth Rate (2015-2026)
Figure 17. Europe Oncology Injection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Oncology Injection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Oncology Injection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Oncology Injection Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Oncology Injection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Oncology Injection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Oncology Injection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Oncology Injection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Oncology Injection Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Oncology Injection Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Oncology Injection Drug Players Market Share by Revenue in Oncology Injection Drug 2015 & 2019
Figure 28. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Oncology Injection Drug Revenue Share by Type (2015-2020)
Figure 30. Global Oncology Injection Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Oncology Injection Drug Revenue Share by Application (2015-2020)
Figure 32. Global Oncology Injection Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Oncology Injection Drug Sales Market Share by Type in 2019
Figure 34. United States Oncology Injection Drug Sales Market Share by Type in 2019
Figure 35. Europe Oncology Injection Drug Sales Market Share by Company in 2019
Figure 36. Europe Oncology Injection Drug Sales Market Share by Type in 2019
Figure 37. Europe Oncology Injection Drug Sales Market Share by Application in 2019
Figure 38. China Oncology Injection Drug Sales Market Share by Company in 2019
Figure 39. China Oncology Injection Drug Sales Market Share by Type in 2019
Figure 40. China Oncology Injection Drug Sales Market Share by Application in 2019
Figure 41. Japan Oncology Injection Drug Sales Market Share by Company in 2019
Figure 42. Japan Oncology Injection Drug Sales Market Share by Type in 2019
Figure 43. Japan Oncology Injection Drug Sales Market Share by Application in 2019
Figure 44. Southeast Asia Oncology Injection Drug Sales Market Share by Company in 2019
Figure 45. Southeast Asia Oncology Injection Drug Sales Market Share by Type in 2019
Figure 46. Southeast Asia Oncology Injection Drug Sales Market Share by Application in 2019
Figure 47. India Oncology Injection Drug Sales Market Share by Company in 2019
Figure 48. India Oncology Injection Drug Sales Market Share by Type in 2019
Figure 49. India Oncology Injection Drug Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Oncology Injection Drug
Figure 52. Manufacturing Process Analysis of Oncology Injection Drug
Figure 53. Oncology Injection Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
注射・注入ベースドラッグデリバリーデバイスの世界市場レポート2020 Market Analysis and Insights: Global Injection And Infusion-based Drug Delivery Devices Market The global Injection And Infusion-based Drug Delivery Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Injection And …- 低分子がん治療薬の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Cancer Drug Market The global Small Molecule Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Cancer Drug Scope and Market Size The global Sm…
- ガソリン直噴（GDI）システムの世界市場レポート2020 Gasoline direct injection (GDI), also known as petrol direct injection, direct petrol injection, spark-ignited direct injection (SIDI) and fuel-stratified injection (FSI), is a variant of fuel injection employed in modern two-stroke and four-stroke gasoline engines. The gasoline is highly pressurize…
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drug Market The global Endocrine System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Endocrine System Drug Scope and Market Size The global Endocrine System …
- 消化器系治療薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drug Market The global Digestive System Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Digestive System Drug Scope and Market Size The global Digestive System …